We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+7.89%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$314B
AUM Growth
+$19.1B
(+6.5%)
Cap. Flow
+$92.3M
Cap. Flow
% of AUM
0.03%
Top 10 Holdings %
Top 10 Hldgs %
20.84%
Holding
3,440
New
118
Increased
1,247
Reduced
1,874
Closed
82
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$905M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$585M |
| 3 |
Cisco
CSCO
|
+$554M |
| 4 |
International Flavors & Fragrances
IFF
|
+$456M |
| 5 |
Mastercard
MA
|
+$392M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.37B |
| 2 |
DuPont de Nemours
DD
|
+$556M |
| 3 |
Qualcomm
QCOM
|
+$405M |
| 4 |
Merck
MRK
|
+$333M |
| 5 |
TSMC
TSM
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.31% |
| 2 | Consumer Discretionary | 12.98% |
| 3 | Financials | 12.81% |
| 4 | Healthcare | 12.54% |
| 5 | Communication Services | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
iShares MSCI ACWI ex US ETF
ACWX
$11.8B
| $1.18M | ﹤0.01% |
21,300
| – | – |
|
|
USX
2802
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $1.17M | ﹤0.01% |
99,471
-503
| -0.5% | -$4.63K |
|
|
IIN
2803
DELISTED
IntriCon Corporation
IIN
| $1.16M | ﹤0.01% |
45,252
-1,285
| -3% | -$28.4K |
|
2804
Limoneira
LMNR
$251M
| $1.16M | ﹤0.01% |
66,167
-2,306
| -3% | -$38.1K |
|
2805
iShares MSCI Emerging Markets ETF
EEM
$29.5B
| $1.16M | ﹤0.01% |
21,677
-160,750
| -88% | -$8.8M |
|
2806
United States Lime & Minerals
USLM
$3.44B
| $1.16M | ﹤0.01% |
43,235
+1,420
| +3% | +$38.4K |
|
2807
XBiotech
XBIT
$69.2M
| $1.15M | ﹤0.01% |
74,125
-8,430
| -10% | -$157K |
|
2808
Tilly's
TLYS
$128M
| $1.15M | ﹤0.01% |
101,337
-8,816
| -8% | -$94.4K |
|
|
APLT
2809
DELISTED
Applied Therapeutics
APLT
| $1.15M | ﹤0.01% |
61,079
+2,704
| +5% | +$58.3K |
|
2810
Fathom Holdings
FTHM
$25.2M
| $1.14M | ﹤0.01% |
31,245
+14,253
| +84% | +$583K |
|
|
JKS
2811
JinkoSolar
JKS
$891M
| $1.14M | ﹤0.01% |
27,247
-106,980
| -80% | -$6M |
|
|
ATHX
2812
DELISTED
Athersys, Inc. Common Stock
ATHX
| $1.14M | ﹤0.01% |
25,248
-728
| -3% | -$37.8K |
|
2813
Atlanta Braves Holdings Series A
BATRA
$3.43B
| $1.13M | ﹤0.01% |
39,483
-1,396
| -3% | -$40.2K |
|
|
PRTK
2814
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $1.12M | ﹤0.01% |
158,885
-6,388
| -4% | -$46K |
|
2815
Vera Bradley
VRA
$98.7M
| $1.12M | ﹤0.01% |
110,941
+4,206
| +4% | +$39.6K |
|
2816
Protagonist Therapeutics
PTGX
$9.44B
| $1.12M | ﹤0.01% |
144,700
+32,129
| +29% | +$813K |
|
2817
BayCom
BCML
$333M
| $1.11M | ﹤0.01% |
61,815
-2,669
| -4% | -$43.6K |
|
2818
LifeVantage
LFVN
$85.3M
| $1.11M | ﹤0.01% |
118,572
-874
| -0.7% | -$8.15K |
|
|
CURO
2819
DELISTED
CURO Group Holdings Corp.
CURO
| $1.1M | ﹤0.01% |
75,689
+2,729
| +4% | +$40.9K |
|
|
MCBC
2820
DELISTED
Macatawa Bank Corp
MCBC
| $1.1M | ﹤0.01% |
110,288
-3,640
| -3% | -$33.4K |
|
|
SYRS
2821
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $1.1M | ﹤0.01% |
14,661
+220
| +2% | +$22.9K |
|
2822
Red River Bancshares
RRBI
$659M
| $1.09M | ﹤0.01% |
19,500
-723
| -4% | -$38.6K |
|
|
ZYXI
2823
DELISTED
Zynex
ZYXI
| $1.08M | ﹤0.01% |
77,738
-271,312
| -78% | -$4.14M |
|
|
QTNT
2824
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $1.08M | ﹤0.01% |
7,312
+214
| +3% | +$42.3K |
|
2825
SoundThinking
SSTI
$103M
| $1.07M | ﹤0.01% |
30,606
-1,731
| -5% | -$75.3K |
|
Similar funds
VFT
Nuveen's Q1 2021 Portfolio in Review
As of Q1 2021, Nuveen held 3,440 positions worth $314B, up 6.5% from $295B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Nuveen's Q1 2021 filing shows 118 new, 1,247 increased, 1,874 reduced and 82 closed positions. Its largest new stake was Coupang: 6,313,287 shares worth $312M. The largest sale was Apple, an estimated $1.37B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Financials.
- Nuveen's largest Q1 2021 buy was Coupang: 6,313,287 shares worth $312M.
- Nuveen added most to Intel in Q1 2021, an estimated $905M increase.
- Nuveen's biggest Q1 2021 reduction was Apple, cutting an estimated $1.37B.
- Nuveen fully exited PARSLEY ENERGY INC in Q1 2021, selling an estimated $122M.
- Nuveen's ten largest holdings make up 21% of its $314B portfolio in Q1 2021.
- Nuveen opened 118 new positions and closed 82 in Q1 2021.
- Nuveen's portfolio value rose 6.5% quarter-over-quarter to $314B.
Based on Nuveen's 13F filing for Q1 2021, filed 17 May 2021.